The research team recruited 104 male patients who met DSM-5 criteria for opioid use disorder and were in sustained remission on medication. Each participant completed a battery of validated instruments: the Addiction Profile Index (API) to measure addiction severity, the Rosenberg Self-Esteem Scale (RSES) to assess global self-worth, the Substance Use Stigma Mechanism Scale (SU-SMS) to capture both anticipated and internalized stigma, the Arizona Sexual Experiences Scale (ASEX) as a screening tool, and the Golombok–Rust Sexual Satisfaction Inventory (GRISS) for a detailed multidimensional profile of sexual function and satisfaction. Sexual dysfunction was defined using established ASEX cut-off scores, giving the study a clear, clinically anchored endpoint rather than relying solely on continuous scores.

The headline number is striking: 36.5 percent of the men—38 out of 104—met criteria for sexual dysfunction. That is a substantial burden in a group that was, by definition, clinically stable and in remission, suggesting that sexual health problems persist well beyond acute withdrawal and may be an underrecognized feature of long-term recovery from opioid dependence. Opioids are well known to suppress the hypothalamic–pituitary–gonadal axis, lowering testosterone and dampening libido, but this study shifts attention toward psychological and social mechanisms that operate alongside these biological effects.

When the researchers compared patients with and without sexual dysfunction, most expected differences failed to materialize. Sociodemographic variables showed no significant associations except for income level, where patients with dysfunction differed from those without (p = .025). Perhaps more surprising, scores on the Addiction Profile Index and the Rosenberg Self-Esteem Scale did not differ significantly between the two groups when compared directly. This pattern hinted that sexual dysfunction in this population is not simply a marker of more severe, more visible illness, but something that cuts across the clinical picture in subtler ways.

Correlation analyses told a richer story. Higher API scores—indicating greater addiction severity—were positively associated with the GRISS total score and with subscales measuring difficulties with touching, avoidance, and satisfaction. In other words, men whose addiction was more severe reported more avoidance of intimacy, less satisfaction, and greater overall sexual difficulty. Anticipated stigma, the fear of being judged or discriminated against because of one’s substance use history, and internalized stigma, the shame a person absorbs and turns inward, were both positively correlated with several GRISS subscales and with ASEX scores. The direction of these associations is intuitive but clinically important: the more a man expects rejection or carries internalized shame about his addiction, the more his sexual functioning suffers.

To test whether these correlations reflected independent effects, the team ran multiple linear regression models. The model predicting the GRISS total score was statistically significant as a whole, although no individual predictor reached significance on its own—a signal that stigma, addiction severity, and related variables likely contribute jointly rather than in isolation. The picture sharpened for the satisfaction subscale: that model was significant, and the API total score emerged as an independent predictor of sexual satisfaction. Addiction severity, in other words, left its clearest fingerprint on how satisfied men felt with their sexual lives, even after accounting for stigma and self-esteem.

The most theoretically ambitious part of the study was its mediation analysis. The authors hypothesized that internalized stigma might erode self-esteem, and that damaged self-esteem might in turn drive sexual dysfunction—a plausible psychological cascade that has support in other stigmatized health conditions. The data did not support it. Self-esteem did not mediate the relationship between internalized stigma and sexual dysfunction in this sample. However, within that same model, addiction severity remained significantly associated with the GRISS total score, reinforcing the idea that the burden of addiction itself, rather than its psychological downstream effects on self-worth, is the more robust correlate of sexual problems in men recovering from OUD.

Why might self-esteem fail as the explanatory bridge? One possibility is measurement and range: the Rosenberg scale captures global self-worth, whereas the mechanisms linking stigma to sexual function may be more specific—performance anxiety, fear of intimacy, relational insecurity, or hypogonadism-related physiological changes that stigma merely amplifies. Another possibility is that in a remitted, medicated sample, self-esteem has partially rebounded while stigma and the neuroendocrine legacy of opioid exposure persist. Cross-sectional designs also cannot establish directionality: sexual dysfunction may itself fuel shame and perceived stigma, reversing the presumed causal arrow. The authors are appropriately cautious, noting that the independent predictive effects they observed were modest.

The clinical implications are nonetheless concrete. Men receiving medication for opioid use disorder are rarely asked about sexual health in routine psychiatric care, yet more than a third of this sample reported clinically significant dysfunction. Because sexual difficulties can undermine intimate relationships, self-image, and treatment retention, the authors argue that routine assessment of sexual functioning, addiction severity, and stigma should be integrated into OUD care. Validated tools such as the ASEX and GRISS make such screening feasible in busy clinics, and identifying stigma as a modifiable psychosocial factor opens the door to targeted interventions, from stigma-reduction psychotherapy to couple-based approaches that address avoidance and dissatisfaction directly.

The study also carries a broader message for how addiction is understood. Stigma is often framed as a barrier to seeking treatment; this work suggests it may also permeate life during treatment, shaping intimacy and satisfaction long after opioid use stops. Anticipated and internalized stigma correlated with sexual difficulties even in men stabilized on buprenorphine–naloxone, implying that recovery programs that address only abstinence and craving may be leaving a significant dimension of quality of life unaddressed. As the authors conclude, greater addiction severity and stigma are linked to more severe sexual dysfunction in men with opioid use disorder, and attending to sexual health, severity, and stigma together may be clinically relevant to durable recovery. For a population already carrying heavy social burdens, that reframing could matter as much as any single statistic.

Subject of Research: The relationship between stigma, self-esteem, addiction severity, and sexual dysfunction in men with opioid use disorder in remission on buprenorphine–naloxone treatment.

Article Title: Examining the relationship between stigma, self-esteem, and sexual dysfunction in patients with opioid use disorder

Article References: Niazi, S., Yazici, A. B., Bardakçı, M. R., Akbulut, K., & Yazici, E. (2026). Examining the relationship between stigma, self-esteem, and sexual dysfunction in patients with opioid use disorder. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08616-7

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08616-7

Keywords: opioid use disorder, sexual dysfunction, stigma, self-esteem, addiction severity, buprenorphine-naloxone, remission, ASEX, GRISS, medication-assisted treatment, psychiatry, men's health

The research, led by Anuki Amarakoon, Jana Galley, and senior author Gillian Einstein at the University of Toronto, combined validated questionnaires with in-depth interviews. In the quantitative arm, 103 women completed the Female Sexual Function Index (FSFI), a 19-item inventory covering desire, arousal, lubrication, orgasm, satisfaction, and pain, along with the revised Female Sexual Distress Scale (FSDS-R), which measures how worried or upset women feel about their sex lives. The researchers compared four groups: women with BRCA1/2 mutations who had RRBSO and were not taking estradiol therapy, women with RRBSO who were taking it, age-matched women with intact ovaries and regular menstrual cycles, and older women in spontaneous menopause who were roughly ten years older on average.

The results were striking. Women who had RRBSO without estradiol therapy scored significantly lower on total sexual function than age-matched controls, with a large effect size, and they reported significantly more sexual distress than both the controls and the older spontaneously menopausal women. On the distress scale, the RRBSO group’s average exceeded the clinical cutoff of 11, indicating risk of clinically significant sexual distress. Notably, age itself was not a significant predictor of any sexual outcome, suggesting that the endocrine upheaval of surgical menopause—not the passage of years—drives the differences.

Perhaps the most consequential finding concerns estradiol therapy. Women taking the hormone after surgery did not differ significantly from those not taking it on total sexual function, and their distress scores did not fall to the low levels seen in age-matched controls. Estradiol therapy appeared to help some women—those on it did not differ significantly from controls on total function or distress—but the variability was wide, and the therapy clearly did not ameliorate all aspects of sexual response for everyone. As the authors put it, estradiol therapy is not a silver bullet, echoing their earlier work showing that the same treatment rescues some cognitive functions after RRBSO but not others.

Depressive symptoms emerged as a powerful and previously underappreciated factor. Using the Center for Epidemiologic Studies Depression Scale (CES-D), the team found that as depressive symptoms rose, total sexual function, arousal, lubrication, and satisfaction fell, while sexual pain and sexual distress climbed. Women with RRBSO who were not on estradiol therapy averaged slightly above the clinical depression cutoff of 16. The authors note that prior research has documented a roughly twofold risk of new-onset depressive symptoms within a year of the surgery, and they suggest that treating mood may help relieve sexual difficulties—though the study cannot determine which condition drives the other.

The qualitative half of the study added a dimension questionnaires cannot capture. Fourteen women with BRCA1/2 mutations who had undergone RRBSO were interviewed about their memory after surgery, with no questions about sex. Thirteen of them spontaneously brought up their sexual lives anyway—a telling measure of how central the changes had become. Thematic analysis yielded six themes: loss of desire, vaginal dryness, sexual pain, strain on the marriage bed, questions of identity and the self, and the insistence that women care deeply about sex.

The women’s words were often stark. One participant, taking estradiol therapy, likened her vanished libido to an appetite: “Physically, I wasn’t craving that aspect because it’s like if you were hungry or not hungry. I just felt like I had no appetite for it whatsoever.” Another said simply, “I don’t have any libido. There’s nothing.” Several described the loss as nearly immediate after surgery. Even a woman whose desire returned with added testosterone therapy described it as an “artificial trigger,” leaving her uncertain whether what she felt was genuine or merely physiological. Burning vaginal pain was nearly universal in the narratives, and some women reported that dryness and pain persisted despite hormone treatment, while others were spared—underscoring the individual variability in response.

The repercussions extended well beyond the bedroom. Women worried that sexual difficulties were eroding their marriages, with one noting that relationships highly dependent on physical appearance or sexual frequency were particularly vulnerable. Another was surprised not only by lost sexual intimacy but by the disappearance of ordinary touching. Participants also linked the changes to their sense of self, describing feeling older and associating sexuality with vitality and youth. One woman, denied the quick pharmaceutical fixes available for male erectile dysfunction, captured the frustration in the study’s title: “There’s no magic pill to help me, right?”

Underlying many accounts was a failure of informed consent. Although the sexual consequences of RRBSO have been documented in the literature since at least 1992, most participants said they were inadequately informed about what the surgery would do to their sex lives. Some were warned about hot flashes and weight changes but never about lost desire. Others knew the risk existed but did not truly understand it. The authors argue that being told something is not the same as understanding it, and that fully informed consent requires candid discussion of the possible sexual ramifications—including their persistence and magnitude—before women commit to the operation.

The study has limitations worth noting. The cohort was predominantly Canadian, white, and highly educated; the FSFI carries a known dysfunction bias; and the researchers did not quantify hormone doses or estradiol levels, limiting causal conclusions. Only a handful of participants were taking testosterone, so its potential benefits—supported by randomized trials showing that transdermal testosterone at physiological doses improves desire and satisfying sexual activity in surgically menopausal women—could not be assessed here. Still, the convergence of numbers and narratives makes the central message hard to ignore: women value their sexual lives, estradiol therapy alone will not restore them for everyone, and clinicians owe patients a far more honest conversation before they consent to losing their ovaries.

Subject of Research: Sexual function and distress after risk-reducing bilateral salpingo-oophorectomy in women with BRCA1/2 mutations

Article Title: “There’s No Magic Pill to Help Me, Right?”: Sex After Early Midlife Bilateral Salpingo-Oophorectomy

Article References: Amarakoon, A., Galley, J., Perović, M., Karkaby, L., Galper, M., & Einstein, G. (2026). “There’s No Magic Pill to Help Me, Right?”: Sex After Early Midlife Bilateral Salpingo-Oophorectomy. Archives of Sexual Behavior. https://doi.org/10.1007/s10508-026-03548-5

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03548-5

Keywords: BRCA1/2, bilateral salpingo-oophorectomy, surgical menopause, estradiol therapy, sexual dysfunction, sexual distress, female sexual function, depressive symptoms, informed consent, testosterone therapy, cancer risk reduction, menopause

A new study by Taranjot Bedi-Padda, Christine Purdon, and Uzma S. Rehman at the University of Waterloo, published in Archives of Sexual Behavior, is the first to test whether non-erotic thoughts vary across cultures. The researchers compared second-generation South Asian women with White women living in Canada, the United States, and the United Kingdom. Their motivation was straightforward. South Asian sexual norms, across many communities, tend to emphasize procreative sex within marriage, sexual modesty, and the containment of female desire. When those norms are transgressed, guilt and shame are common emotional consequences. If culture shapes the content of sexual cognition, the researchers reasoned, it should show up most clearly in thoughts tied to moral evaluation and to the practical consequences of sex, such as pregnancy and infection.

To find out, the team recruited two independent samples through the online research platform Prolific: 301 women in the first sample and 284 in the second, each containing both White women and second-generation South Asian women. Participants completed a modified version of the non-erotic thoughts measure developed by Purdon and Holdaway in 2006, which asks respondents to report how frequently specific categories of intrusive thoughts occur during sexual activity and how much anxiety each one produces. The design—two separate samples, a validated instrument, and pre-specified culturally relevant categories—was intended to guard against the possibility that any single result was a statistical fluke.

The headline finding is one of nuance rather than blanket difference. Overall, the total frequency of non-erotic thoughts and the total anxiety attached to them did not differ significantly between South Asian and White women. Culture, in other words, did not make South Asian women more distractible in general during sex. But when the researchers broke the thoughts down into their constituent categories, two domains stood out with striking consistency across both samples: thoughts concerning morality, guilt, and regret, and thoughts concerning pregnancy, sexually transmitted infections, and health. In both cases, South Asian women reported both higher frequency and higher anxiety than their White counterparts, with effect sizes in the small-to-moderate range, Cohen’s d ranging from 0.24 to 0.53.

That pattern is theoretically meaningful. It suggests that cultural influence on sexual cognition is domain-specific rather than global. The moral architecture of a community does not flood the mind with more distractions overall; it selectively amplifies the distractions that touch the community’s most charged taboos. For women raised amid norms of sexual modesty and expectations of premarital chastity, a moment of desire can trigger a cascade of evaluative thoughts—Am I doing something wrong? What will this mean about who I am?—precisely the kind of self-focused cognition that Barlow’s model identifies as a pathway to sexual dysfunction. The parallel elevation of pregnancy and STI concerns fits the same logic, since fear of visible consequences carries heightened social cost in communities where sexual activity outside marriage is stigmatized.

The second sample added further category-level differences beyond the two robust ones, hinting that the cultural fingerprint on sexual cognition may extend into additional domains. The authors note that the largest effects emerged for morality and guilt thoughts, a result they read as consistent with cultural norms emphasizing sexual modesty. The convergence of two independent samples on the same two categories is the study’s strongest card: whatever measurement noise exists, the morality and health-concern effects replicated.

The study also carries weight for a broader reason. Psychology’s reliance on what Joseph Henrich and colleagues famously called the WEIRD—Western, educated, industrialized, rich, democratic—population has long distorted the field’s picture of human nature, and sexuality research is no exception. Measures of sexual function, norms of desire, and models of arousal have been built largely on White Western samples and then assumed to be universal. By demonstrating that a well-established cognitive phenomenon looks different in a culturally distinct group, the Waterloo team adds sexuality to the growing list of domains where the universality assumption fails, at least in part.

The choice to study second-generation South Asian women is itself telling. These are women navigating two sets of scripts simultaneously: the liberalized sexual culture of Canada, the United States, or Britain, and the familial and religious expectations transmitted from South Asian heritage communities. Prior qualitative work has described the resulting tension—women caught between omissions, in the words of one dissertation cited by the authors, where parents avoid discussing sexuality and community norms discourage premarital sex while mainstream culture normalizes it. The current findings give that lived tension a quantitative signature: it surfaces, measurably, in the intrusive thoughts that accompany sexual activity.

There are clinical implications. Mindfulness-based interventions, which train attention back toward erotic sensation and away from distracting cognition, have shown promise for women’s sexual arousal difficulties in trials led by Lori Brotto and colleagues. But if the distracting content itself is culturally patterned, then therapy that ignores moral and health-related worries may miss the very cognitions that carry the most anxiety for some clients. The authors argue that their findings underscore the need for culturally sensitive models of sexuality and culturally adapted therapeutic approaches—acknowledging, for instance, that guilt about transgressing sexual norms is not a generic cognitive distortion but a reflection of genuinely held community values that treatment must navigate rather than dismiss.

The study is not without limits. It relies on self-report during a single assessment, samples were recruited online rather than clinically, and the South Asian category spans enormous internal diversity—of religion, region, and family migration history—that a two-group design cannot capture. Effect sizes, while replicated, are modest, and the cross-sectional data cannot say whether cultural norms cause the thought patterns or merely correlate with them. Still, as a first empirical bridge between the cognitive literature on sexual distraction and the anthropology of sexual shame, the study makes a clear claim: the mind wanders during sex everywhere, but where it wanders depends on where you come from. For researchers, that means NET measures need cultural validation before export. For clinicians, it means asking not just whether a client is distracted during intimacy, but what, exactly, the distraction is saying—and whose voice it carries.

Subject of Research: Cultural differences in non-erotic intrusive thoughts during sexual activity among South Asian and White women

Article Title: Distraction and Desire: Extending the Study of Non-Erotic Thoughts to the South Asian Context

Article References: Bedi-Padda, T., Purdon, C., & Rehman, U. S. (2026). Distraction and Desire: Extending the Study of Non-Erotic Thoughts to the South Asian Context. Archives of Sexual Behavior. https://doi.org/10.1007/s10508-026-03545-8

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03545-8

Keywords: non-erotic thoughts, cross-cultural sexuality, sexual dysfunction, South Asian women, cognitive interference, sexual guilt, sexual anxiety, second-generation immigrants, sexual modesty, women's sexual health, cultural psychology, Archives of Sexual Behavior

The study, led by Safa Mousavi of Tabriz University of Medical Sciences together with colleagues at Mazandaran University of Medical Sciences, recruited 219 partners of patients with confirmed heart failure between February 2022 and January 2023. Participants were drawn from both inpatient wards and outpatient clinics using consecutive sampling, a technique in which every eligible person who presents during the recruitment window is invited to take part. To qualify, partners had to have been married to the patient for at least one year and be willing to participate. The researchers recorded the patient’s left ventricular ejection fraction — the percentage of blood the left ventricle pumps out with each contraction, and the single most important number in classifying heart failure severity — splitting cases into those with an ejection fraction of 30 percent or less and those above 30 percent.

Sexual satisfaction was measured with Larson’s Sexual Satisfaction Questionnaire, a validated instrument that asks respondents to rate multiple dimensions of their sexual relationship, including communication, affection, and the frequency and quality of sexual activity. The team then applied a battery of statistical tests: independent t-tests to compare group means, one-way analysis of variance to compare multiple groups, Pearson correlation to measure linear associations between continuous variables, and multiple linear regression to isolate which factors independently predicted satisfaction scores. A p-value of 0.05 or below was treated as statistically significant throughout. This layered approach matters, because simple correlations can be misleading — older couples tend to have been married longer, for instance, so teasing apart which variables carry independent weight requires regression modeling.

The correlational findings painted a consistent picture. Sexual satisfaction declined significantly as the partner’s age rose (a correlation coefficient of −0.196, with a p-value of 0.004), as the patient’s age rose (−0.197, p = 0.003), and as the duration of the marriage increased (−0.211, p = 0.002). These coefficients are modest in magnitude but statistically robust, and they align with a broader clinical literature showing that both aging and chronic illness erode sexual wellbeing. In heart failure, the physiological mechanisms are well documented: reduced cardiac output limits blood flow to the genital vasculature, medications such as beta-blockers and diuretics can dampen libido and arousal, and the fear of triggering dyspnea, arrhythmia, or chest pain during exertion casts a psychological shadow over intimacy for both members of the couple.

But the most striking results emerged from the multivariable regression, which controlled for the overlapping effects of age, marriage length, and illness severity. Three factors stood out as independent predictors of sexual satisfaction: whether the couple had children, the type of marriage, and the partner’s employment status. The presence of children was the dominant signal. Partners without children scored an average of 80.69 on the satisfaction scale, compared with 73.38 for those with children — a gap of more than seven points that was highly significant, with a p-value below 0.0001. The authors suggest that psychosocial and family-related burdens, including caregiving demands and the diversion of emotional and physical energy into parenting, may compound the strain that heart failure already places on a couple’s intimate life.

The other two independent predictors are equally revealing. Type of marriage — a variable with particular cultural salience in Iran, where arranged and self-chosen marriages coexist — reached significance at p = 0.012, indicating that the circumstances under which a couple formed their bond shape how well their sexual relationship weathers chronic illness. Employment status of the partner was also independently associated with satisfaction (p = 0.004), plausibly reflecting differences in stress, fatigue, financial pressure, and the time available for the relationship. Notably, the patient’s ejection fraction category did not emerge as an independent driver of partner satisfaction in the regression, a finding that challenges the intuitive assumption that a weaker heart automatically means a less satisfying intimate life. The subjective and relational context, the data suggest, may matter as much as the pump itself.

Why does this matter clinically? Sexual dysfunction is one of the most common yet least discussed consequences of cardiovascular disease. Surveys across cardiology settings consistently show that patients want to talk about sexual problems but rarely do, and clinicians rarely ask — a mutual silence that leaves a treatable aspect of quality of life unaddressed. This study extends that conversation to the partner, who is often the patient’s primary caregiver and whose own wellbeing is tightly coupled to the patient’s recovery and adherence to treatment. A partner experiencing low sexual satisfaction may also be experiencing depression, caregiver burnout, or relational distress, all of which can undermine the home-based support system on which heart failure management depends. Heart failure care is, in a real sense, delivered at home, and the home’s emotional climate is a clinical variable.

The study’s design carries caveats that readers should keep in mind. As a cross-sectional analysis, it captures a single moment in time and cannot establish causation: it cannot tell us whether low sexual satisfaction follows heart failure, precedes it, or arises from shared underlying factors such as aging or socioeconomic strain. The sample came from a single hospital in Sari, a city in Mazandaran province, and cultural norms in northern Iran may shape both how participants experience intimacy and how willing they are to report on it honestly, even on an anonymous questionnaire. Consecutive sampling from one center also limits how far the findings generalize to other regions and health systems. The self-reported nature of the satisfaction measure introduces the possibility of social desirability bias, particularly on a topic that remains sensitive in many communities.

Even with those limitations, the work fills a genuine gap. Most research on sexuality and heart disease focuses on the patient — typically on erectile dysfunction in men with coronary artery disease — while the partner’s experience is treated as an afterthought. By quantifying partner satisfaction and identifying modifiable correlates such as family structure, employment, and marital context, the Iranian team gives clinicians a concrete checklist for a conversation that almost never happens. The authors argue that their findings highlight the importance of addressing psychosocial and family-related factors in the care of heart failure patients and their partners, and the data back that argument: the strongest predictors of low satisfaction were not measures of cardiac function but measures of family life.

The practical implications are straightforward. Cardiac rehabilitation programs, which already monitor exercise capacity, diet, and mood, could incorporate brief sexual health screenings for both patients and partners, normalized as part of routine follow-up. Counseling that addresses fear of exertion during intimacy — much of which is based on outdated risk perceptions — has been shown in other cardiac populations to restore confidence and activity. And recognizing that couples with children and employed partners face distinct pressures could help tailor support services. The study received no external funding, was approved by the ethics committee of Mazandaran University of Medical Sciences, and was conducted in accordance with the Declaration of Helsinki, with informed consent from all participants. Its message, however, costs nothing to act on: the heart fails in one body, but the consequences are shared by two people, and good cardiac care should count both of them.

Subject of Research: Sexual satisfaction among partners of patients with heart failure

Article Title: Sexual satisfaction among partners of patients with heart failure: a cross-sectional study in Sari, Iran

Article References: Mousavi, S., Valipourkoleti, A., Malekrah, A., & Nouri, B. (2026). Sexual satisfaction among partners of patients with heart failure: a cross-sectional study in Sari, Iran. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00485-5

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00485-5

Keywords: heart failure, sexual satisfaction, partners, cross-sectional study, Iran, sexual dysfunction, cardiology, psychosocial factors, Larson questionnaire, caregivers, quality of life, marital relationship

The study, the first of its kind conducted in Türkiye, used individual semi-structured interviews with four first-time mothers and six women who had given birth before, with a mean age of 29 years. Interviews lasted 30 to 40 minutes and were analyzed using the thematic analysis framework of Braun and Clarke, with recruitment continuing until data saturation was reached. Three dominant themes emerged from the analysis: avoidance of sexuality, maintaining sexuality as a responsibility, and coping with the effects of breastfeeding on sexuality. Within these, the researchers identified six subthemes ranging from physical and psychological changes in sexual dynamics to religious and cultural influences, the fulfillment of the female role, changing perceptions of breasts, and the coping strategies women improvised to manage it all.

The physiological backdrop is well established in the literature. Breastfeeding elevates prolactin, the hormone that drives milk production, while suppressing estrogen. The result is a hormonal profile that commonly produces vaginal dryness, reduced libido, and altered sexual responsiveness. A 2025 meta-analysis cited by the authors found that sexual dysfunction was common among postpartum women regardless of feeding method, but rates were highest among those who exclusively breastfed. The mothers in the new study described these mechanisms in visceral, personal terms. One participant who had a vaginal birth with stitches compared resuming intercourse to her very first sexual experience, describing fear, excitement, desire, and obligation all mixed together, and recounting how she tensed up so severely that her husband had to stop. Another, recovering from a cesarean section, reported stinging sensations at her incision sites nearly six months after delivery.

Vaginal dryness emerged as one of the most distressing physical consequences. One mother described using Vaseline to manage severe dryness and pain so intense that she felt sensitivity for two days afterward, even while urinating. She explained that the anticipation of pain had become self-reinforcing: whenever her husband wanted sex, she would tense her legs in expectation of discomfort, to the point that her husband said he no longer enjoyed it either. Breast fullness, tingling sensations, and milk leakage during intimacy further disrupted sexual encounters, with several women reporting that any attempt to touch their breasts triggered pain or an immediate loss of desire.

But the study’s most revealing findings lie beyond physiology. The psychological weight of breastfeeding shaped sexual experiences in ways that clinical checklists rarely capture. Mothers described chronic fatigue and sleep deprivation, the fear of waking the baby, and anxiety about becoming pregnant again while breastfeeding. One woman recalled a relative who conceived during breastfeeding with only a 13-month gap between children, a pregnancy with twins that left her devastated, and said the same fear haunted her. Others described what one participant called rushed sex: intercourse squeezed into narrow windows before the baby woke, stripped of foreplay and pleasure. She noted that before the child, the couple had sex two or three times a week; now they were grateful for twice a month. Several women reported being unable to reach orgasm at all, and one captured a broader exhaustion, saying that being a woman meant being responsible for the child and the husband while no one asked what she wanted or how she coped.

Feelings of disgust and shame surfaced repeatedly, particularly around the collision of maternal and sexual meanings attached to the breasts. One mother recalled her husband mockingly telling her she smelled of milk while kissing her, a comment she laughed off but which hurt deeply. Another described an incident in which leaked milk soaked her husband’s arm; he initially mistook it for the baby’s urine, and she felt extreme embarrassment, saying she felt like a cow rather than a woman. The same participant described a distinct form of guilt: when milk leaked during sex, she thought of her baby and felt the milk that should be feeding her child was being wasted. These accounts illustrate how lactation can reframe the breast so thoroughly that its sexual role becomes psychologically untenable.

Religious and cultural norms added a further layer, and here the Turkish context proved essential to the study’s contribution. Several participants described avoiding intercourse specifically because of the requirement to perform ghusl, the full ritual ablution required after sexual intercourse before a woman could breastfeed her baby. One mother said she sometimes avoided intercourse for this reason alone, and described rushing to the bathroom to perform ablution while the baby cried in the father’s arms, explaining that she wanted her baby to receive clean milk. Household structure mattered as well: mothers living with in-laws or extended family reported being unable to embrace their husbands, let alone have sex, because an elder might enter the room at any moment. One participant said intimacy with a spouse while elders were in the house felt inappropriate and embarrassing. Even the baby’s presence in the bedroom created a sense of being watched, with one mother insisting the couple had never had sex in front of their child because it felt as though someone was observing them.

Perhaps the most sobering theme was sexuality maintained as duty rather than desire. Multiple women described continuing to have intercourse primarily to satisfy their partners, framing it as a responsibility of their female or spousal role. One mother said her motherhood outweighed everything and her femininity came second, and that if she did not have responsibilities toward her husband she would not force herself to have sex at all. Another asked directly whether it was not a woman’s duty to satisfy her husband, saying she felt she could not fulfill her role as a woman. Alongside this, the study documented how breastfeeding redefined the breasts themselves. Many women came to see them as organs belonging to the infant, instruments of nourishment rather than pleasure, and negotiated explicit agreements with partners that the breasts would not be touched during sex. Yet the picture was not uniformly negative: some participants reported that lactation-related breast enlargement improved their body image and their partners’ attraction, with one hoping the change would persist after weaning.

The women were not passive in the face of these challenges. The researchers catalogued a range of coping practices: keeping bras on during intercourse to contain leakage, expressing milk in advance with a breast pump, setting boundaries about breast contact, and, for some, simply adopting a patient stance that the difficulties would pass with time, as they had after previous births. Notably, participants also called for better education, with one urging that men be taught what their wives experience during breastfeeding so they understand the process. The authors argue that these adaptive strategies, which include redefining intimacy and prioritizing emotional closeness over penetrative sex, may function as a protective factor for relational and sexual well-being, though the exploratory design prevents firm conclusions about their effectiveness.

The study’s limitations are real: a single center, Turkish-speaking participants only, a small sample that cannot be generalized, and a mix of delivery types whose recovery demands may have independently shaped sexual activity. Still, its central message carries broad clinical weight. Breastfeeding and sexuality are intertwined through physical, psychological, social, cultural, and religious threads, and the meanings women attach to milk and motherhood matter as much as prolactin levels. The researchers recommend that healthcare professionals address breastfeeding, breast milk, and sexuality together within breastfeeding education programs, provide individualized and culturally sensitive guidance for couples, and integrate the topic into prenatal education. For the mothers in this study, the tension between being a partner and being a mother was not a passing inconvenience but a defining struggle of the postpartum months, one that most had never been warned about, and one that a more honest conversation between clinicians and couples could help ease.

Subject of Research: Breastfeeding mothers' perceptions and experiences of breast milk and sexuality during the postpartum period

Article Title: Being a Partner or a Mother: Breastfeeding Mothers’ Perceptions and Experiences of Breast Milk and Sexuality in the Postpartum Period

Article References: Akbaş, P., & Özkan Şat, S. (2026). Being a Partner or a Mother: Breastfeeding Mothers’ Perceptions and Experiences of Breast Milk and Sexuality in the Postpartum Period. Archives of Sexual Behavior. https://doi.org/10.1007/s10508-026-03540-z

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03540-z

Keywords: breastfeeding, postpartum sexuality, breast milk, qualitative research, prolactin, vaginal dryness, religious norms, maternal role, body image, Türkiye, sexual dysfunction, coping strategies

The World Health Organization defines sexual health as a state of physical, emotional, mental, and social well-being in relation to sexuality, not merely the absence of dysfunction. By that broad standard, cancer is a formidable adversary. Estimates cited in the study suggest that over 90 percent of cancer patients experience some form of sexual dysfunction, ranging from diminished libido and altered satisfaction to difficulties with arousal. Despite this prevalence, clinicians are less likely to raise sexual health with patients on life-prolonging or palliative treatments than with those pursuing curative care, and prior research indicates that discussions about treatment effects on sexual function reach men roughly twice as often as women, at rates of 64 percent versus 28 percent.

The Malaysian study recruited participants from an oncology outpatient clinic at a private quaternary hospital between March 2023 and March 2024. Eligible patients had advanced solid-organ cancer, were at least 18 years old, had a sexual partner, and were proficient in English. The average participant was 49.1 years old, 63.3 percent were women, and 82.5 percent had good performance status as measured by the Eastern Cooperative Oncology Group scale, where lower scores indicate better physical function. Breast cancer was the most common diagnosis at 28.3 percent, followed by gastrointestinal malignancies at 26.7 percent and lung cancer at 13.3 percent. Most participants were married, lived with their partner, and had been in their relationship for more than two decades.

Participants completed the EORTC QLQ SH-22, which assesses functional domains such as sexual satisfaction, activity, libido, and partner relationships alongside symptom domains including sexual pain, vaginal dryness, erectile function, fatigue, and treatment impact. Scores are transformed to a 0 to 100 scale, with higher values indicating more severe symptoms or dysfunction. The researchers supplemented this with the six-item Female Sexual Function Index, adapted so that the lubrication item also captured erection, and with single-item measures of self-esteem, life satisfaction, and relationship satisfaction rated on seven-point scales. Statistical analysis employed Pearson correlations, independent t-tests, analyses of variance, and multiple linear regression using SPSS version 25, with effect sizes interpreted according to Cohen’s conventions.

One of the most striking findings was that 51.6 percent of participants reported sexual activity within the previous four weeks, a figure that contrasts sharply with studies from other populations. Research cited by the authors found that nearly 60 percent of highly educated men with advanced cancer in stable relationships had abstained from sexual activity in the preceding month despite yearning for intimacy, while a study of urban Chinese breast cancer survivors found that fewer than one-third had been sexually active in the past year, often fearing that intercourse could impede recovery. The authors suggest that stable long-term partnerships, cultural and relational factors, and the healthcare context may all shape these divergent patterns, underscoring that sexual behavior in serious illness is not determined by disease status alone.

The correlational results revealed clear gender-specific signatures. Among women, better sexual functioning was associated with higher perceived importance of sex (r = 0.60), greater sexual satisfaction (r = 0.61), less vaginal dryness (r = -0.43), less sexual pain (r = -0.33), and less interference of treatment with sex (r = -0.35), all statistically significant. Among men, better functioning tracked with erectile confidence (r = 0.51), perceived importance of sex (r = 0.46), greater satisfaction, and less treatment interference (r = -0.49). Direct comparisons showed that an active sex life mattered more to men than to women, with a moderate effect size (p = 0.005, d = 0.54), while women reported substantially more sexual pain than men, with a large effect size (p < 0.001, d = 0.87).

Physical function emerged as a second major axis of sexual well-being. Patients with poor performance status, defined as an ECOG score of 2 or above, reported significantly greater impact of fatigue on their sex lives (p = 0.010, d = 0.65) and more worries about incontinence (p = 0.013, d = 0.60) than those with good performance status. Interestingly, apparent differences in sexual pain between cancer types dissolved when gender was added to a regression model, suggesting that gender, with its physiological and sociocultural dimensions, exerts a stronger influence on sexual pain than tumor site alone. The authors note that treatments such as surgery, chemotherapy, radiotherapy, and endocrine therapy may contribute to sexual difficulties through effects on body image, fatigue, menopausal symptoms, and organ function.

The sources of sexual distress also diverged sharply by gender. Men who experienced more sex-related stress reported poorer body image, feeling less masculine, greater insecurity about satisfying their partners, and lower sexual satisfaction, consistent with evidence that men place heavy emphasis on sexual performance. Women’s distress, by contrast, was linked to vaginal dryness and worries about incontinence, pointing to physical discomfort as a central driver. Only among women were sexual health variables associated with self-esteem, life satisfaction, and relationship satisfaction; among men, none of the QLQ SH-22 domains correlated significantly with these broader well-being measures. Both genders showed a link between sex-related stress and more communication with health professionals, hinting that distressed patients may actively seek conversations that clinics rarely initiate.

The cultural context of Malaysia adds a distinctive layer to these findings. Norms of modesty, religiosity, and traditional gender roles can inhibit open discussion of sexuality, particularly among older adults and women, contributing to underreporting and unmet needs. Qualitative research from Malaysian hospitals has found that healthcare providers cite embarrassment, limited knowledge, sociocultural taboos, and time constraints when explaining why they avoid sexual health conversations, often prioritizing disease management over comprehensive care. Surveys of Malaysian medical students similarly reveal widespread feelings of being ill-equipped to discuss sexual matters, pointing to gaps in training that begin long before clinical practice.

The authors argue that these findings justify integrating structured sexual health assessment into routine oncology and palliative care. They propose a simple screening question, asking whether cancer or its treatment has affected intimacy or sexual well-being, followed by fuller evaluation with validated instruments such as the QLQ SH-22 for patients who report concerns. Gender-sensitive pathways could offer women management of vaginal symptoms, gynecological assessment, and body image support, while men might benefit from interventions targeting erectile confidence and communication with partners. Referral networks spanning gynecology, urology, psycho-oncology, counseling, and palliative care could support multidisciplinary management. The study’s limitations, including its cross-sectional design, the predominance of educated Malaysian Chinese women in stable relationships, recruitment at a single private center, and the absence of partner perspectives, caution against broad generalization. Even so, the message is clear: sexuality does not disappear with an advanced cancer diagnosis, and culturally responsive, person-centered care must make room for it.

Subject of Research: Sexual health and function in Malaysian patients with advanced cancer assessed using the EORTC QLQ SH-22 questionnaire

Article Title: Exploring sexual health and function among Malaysian patients with advanced cancer: insights from the EORTC QLQ SH-22 questionnaire

Article References: Yaakup, H., Goh, P. H., Mustafa, H., Ho, J. F. V., Lee, Q. Y., Wong, P. L., & Cheong, M. W. L. (2026). Exploring sexual health and function among Malaysian patients with advanced cancer: insights from the EORTC QLQ SH-22 questionnaire. Supportive Care in Cancer, 34(10), Article 1042. https://doi.org/10.1007/s00520-026-11261-1

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11261-1

Keywords: advanced cancer, sexual health, sexual dysfunction, EORTC QLQ SH-22, palliative care, supportive care, quality of life, Malaysia, gender differences, oncology, performance status, patient-reported outcomes

The study drew on data from 356 women who had been diagnosed with breast cancer and were interviewed five years later as part of the VICAN5 survey, a large French national cohort designed to follow cancer survivors’ lives across health, work, and psychosocial domains. To characterize sexual dysfunction, the researchers selected five items from the Relationship and Sexuality Scale, a validated instrument covering dimensions of sexual life relevant to cancer survivors. Because sexual dysfunction is multidimensional, encompassing desire, arousal, comfort, and satisfaction, the team applied latent class analysis, a data-driven method that identifies unobserved subgroups within a population based on patterns of responses across multiple indicators. Instead of imposing arbitrary cutoff scores, latent class analysis lets the data reveal how symptoms cluster together in real people.

The analysis pointed decisively to a three-class model. The largest group, comprising 133 women or 37.4 percent of the sample, experienced moderate sexual dysfunction. A second group of 124 women, or 34.8 percent, reported no or low dysfunction. But the third group, 99 women representing 27.8 percent of survivors, reported high sexual dysfunction five years after diagnosis. In other words, nearly two-thirds of women in remission carried at least a moderate burden of sexual problems, and more than one in four carried a heavy one, at a point in their care when routine oncology follow-up has typically shifted focus to surveillance for recurrence rather than quality-of-life issues.

To understand what distinguished women in the higher-severity classes, the researchers used ordinal logistic regression, a statistical approach suited to outcomes that fall into ordered categories, in this case the ordered severity classes of dysfunction. The strongest association by far was psychological: women who reported feeling less sexually attractive had nearly five times the odds of belonging to a higher dysfunction class, with an adjusted odds ratio of 4.72. This finding places body image at the center of the sexual health picture for breast cancer survivors, consistent with a broader literature linking surgical scars, hair loss, weight changes, and altered breast sensation to diminished sexual self-concept and avoidance of intimacy.

Treatment exposures also left measurable marks. Women who had received radiotherapy had 2.36 times the odds of higher dysfunction, and those still taking adjuvant endocrine therapy at the time of the survey had 1.87 times the odds. Endocrine therapies, including tamoxifen and aromatase inhibitors, are taken for years and work by suppressing estrogen signaling, which can induce menopausal symptoms such as vaginal dryness, hot flashes, and decreased libido even in premenopausal women. The finding that current endocrine therapy use remained associated with sexual dysfunction at five years underscores that these drugs’ side effects are not transient inconveniences but persistent burdens that can erode adherence and quality of life.

Persistent physical symptoms emerged as another cluster of risk factors. Women reporting frequent excessive sweating had 1.67 times the odds of higher dysfunction, and those with frequent paresthesia, abnormal tingling or numbness in the breast or arm, had 1.78 times the odds. Both symptoms point to lasting physiological changes from treatment: vasomotor instability driven by endocrine effects, and nerve injury or sensory loss following surgery and radiation. Breast and nipple sensation plays a documented role in sexual response, and its loss is increasingly recognized as a distinct outcome, sometimes described as sensorisexual function, that deserves attention in its own right rather than being dismissed as a minor sensory change.

The analysis also flagged factors that might be modifiable. Women diagnosed after age 50 had 2.30 times the odds of higher dysfunction, a finding that likely reflects the interplay of natural menopause with treatment-induced hormonal changes. Frequent alcohol consumption was associated with 2.00 times the odds, and use of hypnotic medications, typically prescribed for sleep disturbance, with 1.66 times the odds. The hypnotic finding is particularly intriguing because sedative-hypnotic drugs have known effects on sexual function, and sleep disorders themselves are linked to sexual problems in women. Whether hypnotics are a cause, a marker of underlying distress, or both cannot be resolved in a cross-sectional analysis, but the association suggests that sleep management in survivors may have benefits that extend beyond rest.

The VICAN5 cohort itself deserves attention as a model for survivorship research. Funded by the French National Institute of Cancer, the VICAN surveys followed nationally representative samples of cancer patients at two and five years after diagnosis, capturing not only clinical outcomes but employment, social life, and intimate relationships. This breadth allowed the current analysis to situate sexual dysfunction within women’s whole lives rather than within the clinic alone. The study was approved by French ethics and data protection authorities, and all participants gave informed consent, meeting the standards expected of research touching on highly personal subject matter.

Certain limitations temper the conclusions. The analysis is cross-sectional, meaning it captures a single snapshot at five years and cannot establish whether the associated factors preceded the dysfunction or followed from it. The five RSS items, while validated, provide a narrower window on sexual function than comprehensive instruments such as the Female Sexual Function Index, and the sample of 356 women, though drawn from a national survey, may not represent all survivors, particularly those who declined to answer questions about sexuality. Sexual health questions are notoriously subject to underreporting, which means the true prevalence of dysfunction could be even higher than the study suggests.

Even with those caveats, the message for clinical practice is clear and increasingly urgent. The authors argue that sexual health assessment should be built into routine survivorship care for breast cancer, including dedicated oncosexual consultations, psychosexual support for body image concerns, and active management of persistent treatment symptoms such as vasomotor complaints and neuropathic sensations. Recent trials of newer agents for endocrine-therapy-related vasomotor symptoms show that effective options are emerging, and evidence-based non-pharmacological approaches to sleep and distress are available. What has been missing, the study implies, is the will to ask. Most survivors are never asked about their sexual lives by their oncology teams, and most do not raise the topic themselves. A simple, structured screening question at follow-up visits, targeted especially at women reporting feeling less sexually attractive or struggling with persistent symptoms, could open a door that too many women have been left to face alone.

Subject of Research: Patterns and predictors of sexual dysfunction among breast cancer survivors five years after diagnosis

Article Title: Patterns of sexual dysfunction among breast cancer survivors five years after diagnosis: a latent class analysis of the French VICAN5 study

Article References: Radwan, E., Seguin, L., Provansal, M., Mancini, J., & Bouhnik, A.-D. (2026). Patterns of sexual dysfunction among breast cancer survivors five years after diagnosis: a latent class analysis of the French VICAN5 study. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02108-z

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02108-z

Keywords: breast cancer survivors, sexual dysfunction, latent class analysis, VICAN5, adjuvant endocrine therapy, body image, radiotherapy, paresthesia, vasomotor symptoms, survivorship care, hypnotic use, quality of life

The FSFI has been a workhorse of sexual medicine since its introduction in 2000. The 19-item self-report questionnaire assesses six domains of sexual function over the previous four weeks: desire, arousal, lubrication, orgasm, satisfaction, and pain. Respondents rate each item on a scale, and the domain scores are typically summed into a total score, with a widely used clinical cutoff distinguishing women with and without sexual dysfunction. The instrument was developed and validated in general community and clinical samples of adult women, however—not in people navigating the profound hormonal, anatomical, and relational upheavals of pregnancy and the postpartum period. Whether its scores mean the same thing in those populations had remained largely an open question.

To address it, the research team adopted a contemporary, argument-based approach to validity, guided by modern frameworks that treat validity not as a property of the test itself but of the interpretations and decisions built on its scores. Rather than asking simply whether the FSFI is valid, the researchers examined whether specific claims about what FSFI scores mean in perinatal samples are supported by evidence. This matters because perinatal sexual function is not simply typical sexual function in a different context. Hormonal shifts, tissue changes from delivery, breastfeeding, fatigue, and the psychological transition to parenthood all reshape sexual response in ways that a questionnaire designed for other populations may or may not capture.

The centerpiece of the investigation was a series of factor analyses, statistical techniques that test whether the pattern of people’s answers matches the structure the questionnaire assumes. The results offered a clear verdict on one front: the six-domain structure of the FSFI—desire, arousal, lubrication, orgasm, satisfaction, and pain—was supported in sexually active pregnant and postpartum individuals. In other words, the questionnaire’s underlying architecture holds together in this population, and each domain appears to tap a distinct, coherent aspect of sexual function. That finding gives researchers license to continue using and interpreting the six domain scores with reasonable confidence in perinatal research.

The same could not be said for the total score. Models that assumed a single overarching dimension of sexual function underlying all the items—essentially, the assumption baked into summing everything into one number—were not supported by the data. This is a technically significant result. When a unidimensional model fails, it means the domains are not interchangeable reflections of one common construct, and a total score risks blending genuinely different phenomena into a single, potentially misleading figure. A person might score low overall because of pain alone, for example, while their desire, arousal, and satisfaction remain intact—clinically meaningful distinctions that a total score would obscure. The authors’ conclusion on this point is unambiguous: the use of an FSFI total score is not supported in pregnant and postpartum samples.

Item response theory analyses added a second layer of nuance. These models examine how well each individual item distinguishes between people at different levels of the underlying trait. The findings showed that FSFI items discriminated well at low-to-average levels of sexual function but performed less effectively at higher levels. In practical terms, the questionnaire is most informative for pregnant and postpartum individuals who have poorer sexual function or who are experiencing sexual difficulties. For people functioning well, the items become less precise, meaning small differences among high-functioning individuals may not be reliably captured. This has a silver lining for clinical and research applications focused on identifying and understanding sexual problems, but it cautions against over-interpreting fine-grained differences among people reporting generally healthy sexual function.

The researchers also examined how FSFI domain scores relate to external variables, a standard strategy for testing whether a measure behaves the way theory says it should. With a few exceptions, this evidence indicated that the domain scores are sensitive to real individual differences in sexual function and can distinguish between individuals with and without distressing sexual difficulties. That is, the domains correlate with other measures in sensible ways and show the kind of clinical sensitivity that a useful assessment tool requires. Two domains, however, showed weaker performance: sexual arousal and sexual satisfaction. The authors advise that results from these two domains, like the total score, be interpreted with particular caution in perinatal samples until further evidence accumulates.

The stakes of this psychometric housekeeping are higher than they might appear. Perinatal sexual dysfunction is associated with depression symptoms, relationship dissatisfaction, and distress for both members of a couple, and researchers have increasingly documented trajectories of sexual well-being across the transition to parenthood. Interventions are being developed to support couples’ sexual health during this period, and clinical conversations about resuming intercourse after childbirth depend on accurate assessment. If the field’s dominant measurement tool were quietly mismeasuring these constructs, studies could reach distorted conclusions, clinical cutoffs could misclassify people, and patients’ experiences could be misunderstood. This study provides a foundation of evidence showing which parts of the instrument can be trusted in this population and which cannot.

The work also exemplifies a broader shift in how psychological and sexual health measures are evaluated. Older validation studies often reported a handful of statistics and declared an instrument valid or invalid. Contemporary validity theory, by contrast, builds an integrated argument, weighing evidence from internal structure, item-level performance, and relations to external variables to evaluate specific claims about score interpretation. By applying this framework to the FSFI, the researchers modeled a more rigorous standard for sexuality research, where measurement quality has historically received less scrutiny than in other areas of psychology. The study’s data and analysis code were also made publicly available through the Open Science Framework, supporting transparency and reuse.

For now, the practical guidance is clear. Researchers studying pregnancy and the postpartum period can continue to use the FSFI’s six domain scores as meaningful indicators of the underlying constructs, and the measure appears well suited to identifying individuals with sexual difficulties. But the familiar habit of reporting a single total FSFI score should end in perinatal research, and the arousal and satisfaction domains warrant cautious interpretation. The authors note that further research is needed to address the limitations identified, including the weaker performance at higher levels of function. Until that evidence arrives, this study offers the field something it has long lacked: a clear, evidence-based map of what one of sexual medicine’s most widely used questionnaires can—and cannot—reliably tell us about sexual health during one of life’s most transformative transitions.

Subject of Research: Validation of the Female Sexual Function Index for measuring sexual function in pregnant and postpartum individuals

Article Title: A Validation Study of the Female Sexual Function Index for Use in Pregnant and Postpartum Samples

Article References: Santos-Iglesias, P., Rosen, N. O., & Dawson, S. J. (2026). A Validation Study of the Female Sexual Function Index for Use in Pregnant and Postpartum Samples. Archives of Sexual Behavior, 55(6), 2523-2541. https://doi.org/10.1007/s10508-026-03519-w

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03519-w

Keywords: Female Sexual Function Index, sexual function, pregnancy, postpartum, psychometric validation, factor analysis, item response theory, sexual dysfunction, perinatal health, validity theory, Archives of Sexual Behavior, measurement invariance

The dual control model, first articulated by Erick Janssen and John Bancroft, conceptualizes sexual response as the product of two interacting neurophysiological systems: a sexual excitation system that promotes arousal and desire in response to appropriate stimuli, and a sexual inhibition system that suppresses response in the presence of threat or perceived risk. In this framework, inhibition itself is not a single entity but comprises distinct factors, including inhibitory cognitions—worries, distractions, and catastrophic thoughts about performance or consequences—and inhibition related to performance failure. Excitation, too, is multifactorial, encompassing the ease with which sexual cues generate arousal. The model has proven remarkably useful for understanding individual differences in sexual risk-taking, arousal, and dysfunction, but until now it had not been systematically applied to sexual aversion.

Sexual aversion is defined as extreme aversion to partnered genital sexual contact. It has a long and somewhat turbulent history in psychiatric classification. First described in the clinical literature in the late 1970s and 1980s, sexual aversion disorder was included in the DSM-IV but was subsequently excluded from the DSM-5, with commentators arguing that its symptoms overlapped with other conditions such as specific phobias, panic disorder, and other sexual dysfunctions. Yet researchers have continued to insist on its clinical relevance, noting that aversion appears as a trans-diagnostic symptom across multiple sexual disorders and causes profound suffering in those who experience it. Recent population-based work from Canada has suggested that aversion is not rare, lending urgency to efforts to understand what distinguishes it from superficially similar presentations.

The conceptual puzzle is genuine. Sexual aversion shares behavioral features with asexuality—both involve avoidance of sexual behavior—and both are associated with sexual disgust. But the two diverge sharply on one crucial dimension: distress. For asexual individuals, the absence of sexual attraction or interest is not, in itself, a source of suffering; indeed, many asexual people describe their orientation as a stable identity rather than a problem to be solved. Sexual aversion, by contrast, provokes significant distress. Aversion also shares features with low sexual desire, including avoidance and distress, but the precise relationship between aversion and diminished desire had never been formally established. The Canadian team, led by Nahanni Musiani and senior author Lori Brotto, hypothesized that the dual control model could untangle these threads: if aversion is driven by heightened inhibition, it should be statistically separable from low desire and asexuality, which they predicted would instead be associated with diminished excitation.

To test this, the researchers recruited 2,065 participants who completed a battery of validated self-report questionnaires measuring sexual aversion, sexual desire, asexuality, sexual distress, and the excitation and inhibition factors of the dual control model. Sexual aversion was assessed with instruments developed for that purpose, desire with the Sexual Desire Inventory, and asexual identification with the Asexuality Identification Scale, a measure developed by the same research group. Sexual distress was captured with distress scales validated across genders. The analytic strategy was straightforward and transparent: Pearson correlations were used to map the relationships among variables, and multiple regression models tested which excitation and inhibition factors uniquely predicted aversion, desire, and asexuality. Secondary analyses examined gender differences across the sample.

The results were striking in their clarity. Sexual aversion, asexuality, and low desire were indeed correlated with one another—consistent with their shared surface features—but the correlations were generally modest. Only one association reached moderate strength: the relationship between sexual aversion and sexual distress. This single finding carries enormous conceptual weight, because it confirms empirically what clinicians have long observed anecdotally: distress, not the absence of sex itself, is the signature of aversion. A person can experience little desire or little attraction without suffering; what distinguishes the person with aversion is that contact with sexuality triggers a response they experience as unbearable, and that experience hurts.

The regression analyses went further, revealing that the three outcomes are predicted by different profiles within the dual control model. Sexual aversion was significantly predicted by sexual inhibition—particularly inhibitory cognitions. In other words, the people most prone to aversion were those whose minds generate potent, intrusive, suppressive thoughts in sexual contexts. This is a fundamentally inhibitory profile: the excitation system may be intact, but the braking system is locked. Asexuality, by contrast, was predicted by reduced sexual excitation, with only a weak contribution from increased inhibition. Low sexual desire showed the mirror image: it was predicted by high excitation working in the opposite direction—specifically, low excitation scores predicted low desire—along with a weak role for reduced inhibition. The pattern supports the team’s core hypothesis: aversion is a disorder of excessive braking, whereas asexuality and low desire reflect a quieter accelerator.

The distinction is not merely academic. If aversion is driven by inhibitory cognitions, then treatments should target those cognitions directly. The authors suggest that interventions focusing on sexual inhibition—particularly the cognitive component—may be a promising therapeutic avenue for sexual aversion, an area where evidence-based treatments remain scarce. This aligns with a broader literature showing that cognitive behavioral therapy and mindfulness-based approaches can reduce sexual distress and improve outcomes across sexual dysfunctions, likely in part by modifying the attentional and interpretive processes that fuel inhibition. For clinicians, the message is that a patient presenting with sexual avoidance should not be lumped into a generic category of low libido; assessing the excitation–inhibition profile could determine which treatment pathway is appropriate.

The study also contributes to an ongoing scientific and cultural conversation about asexuality. Research over the past two decades has established that asexuality is a distinct and stable orientation rather than a symptom of disorder, and the new findings reinforce that position in mechanistic terms: asexuality looks like diminished excitation and is not characterized by the pathological inhibition profile seen in aversion. Notably, the study was designed with input from the Asexuality Research Advisory Board, reflecting growing efforts to conduct this research collaboratively with the ace community. Funded by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada and approved by the University of British Columbia’s Behavioral Research Ethics Board, the study exemplifies how large-sample, theory-driven research can resolve classification disputes that have persisted since sexual aversion disorder was first codified. The dual control model, introduced to explain the psychophysiology of arousal, has now proven equally powerful for explaining its absence—and, crucially, for explaining why one form of absence causes suffering while another does not. The findings suggest a future in which sexual avoidance is diagnosed not by behavior alone but by the underlying balance of excitation, inhibition, and distress that produces it.

Subject of Research: Predicting sexual aversion, low sexual desire, and asexuality using the dual control model of sexual response.

Article Title: Predicting Sexual Aversion, Low Sexual Desire, and Asexuality Using the Dual Control Model

Article References: Musiani, N., Zdaniuk, B., Milani, S., Makarenko, B., & Brotto, L. A. (2026). Predicting Sexual Aversion, Low Sexual Desire, and Asexuality Using the Dual Control Model. Archives of Sexual Behavior. https://doi.org/10.1007/s10508-026-03529-8

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03529-8

Keywords: sexual aversion, asexuality, low sexual desire, dual control model, sexual inhibition, sexual excitation, sexual distress, DSM-5, sexual dysfunction, Archives of Sexual Behavior, inhibitory cognitions, sex research

The Wilson and Cleary framework, first proposed in the 1990s and later revised, is one of the most influential conceptual models in outcomes research. It links biological and physiological variables through symptom status and functional health to general health perceptions and, ultimately, overall quality of life. What makes the model useful is its insistence on pathways: it does not simply ask which factors correlate with quality of life, but proposes directional chains through which disease mechanisms are translated into lived experience. Applying this revised model to Parkinson’s disease allowed the study’s authors to test, in a structured and statistically explicit way, which determinants carry the greatest weight along that chain.

Parkinson’s disease is the second most common neurodegenerative disorder worldwide, and its non-motor burden is increasingly recognized as a dominant driver of disability. Depression, anxiety, apathy, sleep disturbance, pain, fatigue, and sexual dysfunction are all more prevalent in Parkinson’s than in age-matched populations, and each has been independently associated with poorer quality of life in prior work. What has been missing, the researchers argue, is an integrated, multidimensional account that places these factors in a single explanatory architecture, rather than treating them as isolated contributors measured one at a time.

The study assembled a battery of validated instruments capturing the model’s successive levels: physiological measures and clinical characteristics of the disease, symptom scales covering both motor and non-motor domains, functional assessments, mental health measures including depressive and anxiety symptoms, and dedicated evaluation of sexual health. Quality of life was assessed with disease-specific and generic instruments, allowing the authors to examine both overall health perceptions and broader life evaluation. Statistical modeling then quantified the direct and indirect effects of each determinant, revealing how influences propagate from biological dysfunction through symptoms and function to the way patients judge their own health.

The headline finding is striking in its simplicity: mental health and sexual function emerged as determinants of quality of life comparable in importance to, and in some pathways stronger than, the classical motor measures that dominate routine neurological assessment. Depressive symptoms in particular acted as a powerful hub, both directly reducing quality of life and mediating the effects of other clinical variables. Sexual dysfunction, which affects a substantial proportion of both men and women with Parkinson’s disease, contributed significantly to poorer health perceptions even after accounting for disease severity, age, and functional status. The authors emphasize that these are not peripheral complaints but central components of the patient experience.

The pathway structure of the revised model proved illuminating. Motor severity influenced quality of life partly through its effect on symptoms and daily functioning, but also through its impact on mood, illustrating an indirect route in which physical decline erodes emotional well-being, which in turn depresses overall life evaluation. Conversely, some non-motor symptoms exerted effects that were largely mediated by mental health, suggesting that psychological state functions as a gateway through which much of the disease’s subjective burden passes. This mediation pattern has practical implications: interventions targeting depression and anxiety may ameliorate the quality-of-life consequences of a range of otherwise distinct symptoms.

Sexual health deserves particular attention in this framework. Sexual dysfunction in Parkinson’s disease arises from a convergence of mechanisms, including dopaminergic degeneration affecting autonomic and limbic circuits, medication effects, motor limitations, relationship strain, and psychological factors. The study’s finding that sexual function retains a significant association with quality of life within a multidimensional model underscores that it is an independent dimension of health, not merely a byproduct of depression or disability. Yet sexual health remains one of the least discussed topics in routine Parkinson’s care, with patients frequently reluctant to raise it and clinicians rarely asking. The authors suggest that structured assessment of sexual function should be incorporated into comprehensive care pathways.

The multidimensional approach also highlights the interdependence of domains often managed by different specialists. Sleep problems feed fatigue; fatigue erodes physical activity; inactivity worsens mood and function; and each step along the chain degrades health perceptions. By modeling these relationships simultaneously, the revised Wilson and Cleary framework provides a map of where interventions might yield the greatest downstream benefit. Treating depression, optimizing dopaminergic therapy, addressing sexual dysfunction, supporting physical function, and attending to social and role functioning are not competing priorities but complementary leverage points on a shared causal network.

For clinicians, the message is that quality of life in Parkinson’s disease is not a simple readout of motor state. Two patients with comparable disease duration and comparable Unified Parkinson’s Disease Rating Scale scores may inhabit radically different subjective worlds depending on their mood, their intimate relationships, and their ability to sustain valued activities. Routine care that measures only the visible layer of the disease risks systematically underestimating the burden carried by those whose motor symptoms are well controlled but whose emotional, sexual, and social health is not. Screening instruments for depression, anxiety, and sexual function are brief, validated, and inexpensive, making systematic implementation feasible in ordinary outpatient settings.

For researchers, the study demonstrates the value of theory-driven models in a field awash with correlational data. Rather than cataloguing associations, the revised Wilson and Cleary model imposes an ordered structure that can be tested, refined, and compared across conditions and populations. The authors note that longitudinal designs will be needed to confirm the directional pathways suggested here, and that interventions designed with the model in mind, for example psychotherapy or sexual health counseling embedded within neurological care, could provide direct tests of its practical utility. If subsequent trials confirm that improving mental and sexual health yields measurable gains in overall quality of life beyond what motor optimization achieves, the study will have helped shift the center of gravity in Parkinson’s care toward a genuinely holistic medicine, one that treats patients not as motors to be tuned but as whole people whose intimacy, mood, and dignity are inseparable from their health.

Subject of Research: Determinants of health-related quality of life in Parkinson's disease, including sexual and mental health, analyzed with the revised Wilson and Cleary model

Article Title: Sexual, mental, and multidimensional determinants of health-related quality of life in Parkinson's disease using the revised Wilson and Cleary model

Article References: Alenko, A., Sudhakar, M., Chelkeba, L., Fomenko, E., & Keygnaert, I. (2026). Sexual, mental, and multidimensional determinants of health-related quality of life in Parkinson's disease using the revised Wilson and Cleary model. Scientific Reports. https://doi.org/10.1038/s41598-026-71122-z

Image Credits: AI Generated

DOI: 10.1038/s41598-026-71122-z

Keywords: Parkinson's disease, quality of life, Wilson and Cleary model, sexual dysfunction, mental health, depression, non-motor symptoms, health-related quality of life, neurodegenerative disease, patient outcomes, Sexual, mental